Investment Team

Health & TechBio

We believe the next decade will be transformational for healthcare and life sciences. 

Advances in computing, technology, and biology are compounding at a dizzying pace. The case for change has never been clearer, yet healthcare remains one of the least digitized sectors of the economy. 

We get excited about founders who are laying the foundation for a more connected and data-driven ecosystem. Those enabling a future that is more personalized,  preventative, and predictive. 

If you’re working on core healthcare or life sciences infrastructure or solutions that can dramatically move the needle on access, costs, or outcomes in areas such as home health, back office automation, clinical trials tech, AI-enabled R&D, pharma and provider software tools, let’s talk!

Initial ticket size

€300K - 2M

We invest in

Pre-Seed & Seed stage startups

Health & TechBio Focused

We have one of the largest and most exciting digital health & TechBio portfolios in Europe. We back bold, visionary founders at the earliest stages of their journey and aspire to be your first call.

Relevant, Real-World Experience

We have built and scaled health & bio startups, practiced medicine, and studied physics, biology & engineering. We get what you do, the “chaos” of the earliest stages, and are obsessed with helping you build, scale, and succeed.

Large & Expanding Network

From our advisors to VCs, experienced founders, providers, payors, and pharma, we connect you with the people you need to succeed. If we don’t have a connection yet, we will hustle with you to find it.

Our Portfolio

Seqera Labs
Seqera Labs

Seqera Labs is on a mission to simplify complex data analysis pipelines in the cloud across pharma, genomics and biotech.

https://seqera.io/

Seqera Labs is on a mission to simplify complex data analysis pipelines in the cloud. Seqera provides software that enables developers and data scientists to create and deploy data applications in any environment. Our core, open-source technology Nextflow transforms the building of massively scalable and distributed computing solutions. Seqera is now empowering customers across pharma, genomics and biotech to break with the status quo of closed-platforms and custom scripts to embrace the Nextflow future of cloud.


Year Invested
2019
Sector
Spain
close button
Spain
Doccla
Doccla

Doccla is building the next-gen virtual ward company

https://www.doccla.com/

Doccla is pioneering the virtual ward technology needed to ease pressure on hospitals and other healthcare providers. Doccla is reinventing remote patient monitoring (RPM) with innovative medical monitoring solutions to deliver safe, effective care from the home. This helps hospitals alleviate the pressure on resources, enabling the early discharge of patients while remaining under the care of clinicians. Industry-leading patient compliance, together with fewer readmissions and lower costs, have direct effects on healthcare providers and patients who can be taken care of in the comfort of their homes.

Year Invested
2021
Sector
United Kingdom
close button
United Kingdom
Orakl Oncology
Orakl Oncology

Orakl Oncology leverages a collection of patient tumor avatars to transform drug development in oncology.

https://www.orakl-oncology.com/

Cancer complexity leads to a 96% failure rate of drug candidates in clinical trials and a shortage of new treatments. Orakl Oncology’s ambition is to finally address the heterogeneity of cancer and patient specificities as early as possible in drug development. By creating a collection of avatars of patients’ tumors, they predict how each patient will respond to future drugs. Orakl Oncology is an interdisciplinary techbio platform that combines best-in-class biology with deep clinical data and machine learning to efficiently discover and optimize new treatments for the right patients. Thanks to their technology, Orakl Oncology works with drug developers to bring better drugs to patients, faster.

Year Invested
2023
Sector
France
close button
France
Doctorly
Doctorly

Doctorly offers a practice management software for doctors.

https://www.doctorly.de/

Doctorly is built upon the Salesforce platform to deliver the most comprehensive yet easy-to-use Software-as-a-Service for doctors. Combined with a cloud storage for electronic health records and a consumer app to communicate with the doctor and access other health-related features, it’s a powerful digital health solution.

Year Invested
2018
Sector
Germany
close button
Germany
Opal
Opal

Become indistractable. Opal can help you take control of your tech.

https://www.opal.so/

Some companies specialize in stealing our time on screens, using features like notifications, infinite scrolling, A.I. curated feeds, subconscious triggers and disappearing stories. Opal helps you take control of your technology, so you can regain time that's been stolen from you. Their app identifies and blocks distractions, allows you to set screen timers, personal intentions for your time, and receive personalized nudges to help you find balance each day.

close button
France
The Lowdown
The Lowdown

The Lowdown is the UK’s leading reproductive and sexual health platform.

https://thelowdown.com/

The Lowdown is a community based women's health review, advice and prescriptions platform. Starting with contraception, they are on a mission to put women in control of their reproductive health decisions through their unique dataset, digital tools and services.

Year Invested
2022
Sector
United Kingdom
close button
United Kingdom
Flinn
Flinn

Flinn is enabling MedTech companies to automate quality & regulatory processes to launch and operate products 10x more efficient.

https://www.flinncomply.com/

Flinn's vision is to make high-quality health products accessible for everyone. The first major milestone on this journey is to enable medical device manufacturers to automate quality and regulatory processes. The go-to-market product sets the focus on the automation of post-market surveillance processes. This means automating the collection, evaluation, and reporting of relevant data through smart workflows, integrations, and the support of AI.

Year Invested
2022
Sector
Austria
close button
Austria
Fertifa
Fertifa

Partnering with Fertifa enables companies of all sizes to truly put into practice their commitments to diversity, equity and inclusion and employee wellbeing for their full workplace.

https://www.fertifa.com/

Having offered fertility clinical advice longer than anyone else in Europe, Fertifa now also provides clinical care advice and wellbeing support for all of women’s health including menopause; men’s reproductive health; and fertility and family-forming. Fertifa is the most inclusive and comprehensive benefits provider for reproductive, hormonal and sexual health, making it accessible for any individual, regardless of gender, sexual orientation, age or relationship status.

Year Invested
2022
Sector
United Kingdom
close button
United Kingdom
Juli
Juli

Juli improves life for people with chronic conditions using an AI-powered platform.

https://www.juli.co/team

Juli integrates previously siloed data like data from smartphones and other wearables, environmental data and EHR data into one platform. All that data is analyzed to identify patterns and give recommendations that guide users towards better health. A patient-centric app allows the user to see their data in one dashboard, keep a journal, get reminders for their medication or be nudged towards micro-behavioural changes in a gamified way. 

juli is a SMART on FHIR platform that integrates easily into all kinds of health systems. This enables care providers to predict when a patient needs additional outreach to avoid a crisis and generates a common understanding of a patient's health status.

Year Invested
2022
Sector
Switzerland
close button
Switzerland
Nilo Health
Nilo Health

The mental well-being support for your entire workforce. Our psychologists, group sessions, and digital content are easily accessible in one app.

https://nilohealth.com/

nilo.health makes high-quality mental health support easily accessible for everyone, enabling employers to conveniently and effectively offer mental health services as a company benefit. Through its evidence-based and confidential platform, nilo.health provides employees with the right level of care based on their individual needs: the support ranges from 1 on 1 sessions with psychologists to group sessions and digital, self-guided tools.

Year Invested
2022
Sector
Germany
close button
Germany
DasLab
DasLab

Building the digital lab test infrastructure for the healthcare ecosystem

https://daslab.health/

DasLab’s vendor-neutral platform bridges the gap between medical diagnostic tests and the latest approaches to healthcare at distance, enabling seamless integration of physical and virtual processes to achieve improved health outcomes. Healthcare providers connect to the platform quickly and securely via an API that uses globally recognized data standards (FHIR & LOINC). 

Once connected, telemedicine providers, digital therapeutics, symptom checkers, and other providers can easily incorporate diagnostic testing and results into their virtual or hybrid care models. Laboratories that integrate with the platform benefit from increased test volume and access to new revenue models.

Year Invested
2022
Sector
Germany
close button
Germany
Charles.co
Charles.co

Charles is a digital clinic specialized in men’s health.

https://www.charles.co/

Charles is a digital clinic that addresses chronic health issues in men, such as sexual health, hair loss, or insomnia. Based in France, the startup offers all its services via an integrated digital platform developed in close collaboration with prominent medical experts on men’s health.

Year Invested
2022
Sector
France
close button
France
MiLaboratories
MiLaboratories

MiLaboratories is the leader in immunome data analysis software with flagship product MiXCR.

https://milaboratories.com/

MiLaboratories is the leader in immunome data analysis software with flagship product MiXCR. MiXCR is a top-notch solution to analyze immunology sequencing data. Our software is used in vaccine, cancer, antibodies, and autoimmune diseases drug development pipelines. We provide a secure, scalable, and fast solution that helps thousands of researchers around the globe to discover new drugs and therapies.

Year Invested
2022
Sector
Spain
close button
Spain
Molecule
Molecule

Molecule's open platform connects life science research to funding.

https://www.molecule.to/

Molecule is creating collaborative ecosystems, where stakeholders in drug development can work together to expedite the process of bringing novel therapeutics to patients. They are connecting leading researchers to funding by turning intellectual property and its development into a liquid and easily investable asset.

Year Invested
2022
Sector
Switzerland
close button
Switzerland
BlubBlub
BlubBlub

“Let’s create a speech therapy tool that kids will love.” That's exactly what Blubblub did!

https://speechblubs.com/

Speech therapists still assign homework on sheets of paper, because the industry has not yet been digitized. BlubBlub decided to change this by introducing its video app, which triggers sounds and words recorded by children and for children, helping them to practice in their specific language to address their specific speech problem. BlubBlub connects children, therapists and parents on one platform to ensure everyone plays a role in each child's progress.

Year Invested
2017
Sector
United States of America
close button
United States of America
9am.health
9am.health

Care that connects it all.

https://join9am.com/

9amHealth offers complete cardiometabolic care—a first-of-its-kind, whole-body approach to preventing and treating diabetes, obesity, high cholesterol, and hypertension. 9amHealth partners with employers, PBMs and healthplans to provide effective health benefits for those living with chronic conditions. Their members receive personalized care plans, prescription delivery, at-home lab tests, and unlimited specialist access.

Year Invested
2021
Sector
Austria
close button
Austria
Rivia
Rivia

AI-driven analytics and data infrastructure for successful Biopharma clinical trials

https://rivia.ch/

Rivia addresses inefficiencies in biopharma clinical trials, where fragmented data and outdated tools hinder the development of new therapies. Their technology offers a real-time, integrated view of data to improve the evaluation of new treatments and trial conduct. Their vision is to become the unified data infrastructure that transforms clinical development lifecycles, bringing new therapies to market more successfully.

Year Invested
2024
Sector
Switzerland
close button
Switzerland
IOMED
IOMED

IOMED helps understand free text in clinical environments to provide big data analysis.

https://iomed.es/

IOMED is a solution that helps understand free text from EHRs, letters, etc. to provide better ICD-10 coding and big data insights for hospitals. It uses sophisticated medical NLP and is seamlessly integrated into the existing IT landscape.

Year Invested
2018
Sector
Spain
close button
Spain
Five Lives
Five Lives

Five Lives builds engaging and accessible digital tools for the tracking and improvement of cognitive health.

https://fivelives.health/

Five Lives builds engaging and accessible digital tools for the tracking and improvement of cognitive health. Their mobile app helps prevent and detect dementia years earlier and at a fraction of the cost of current methods, extending quality of life for millions of people through personalized lifestyle improvements.


The Five Lives team is diverse and experienced with proven ability to build and scale world-leading mobile apps. The core team worked together previously at Peak (60M downloads, 5M monthly active users), is led by successful entrepreneurs and has close input from expert scientific advisors.

Five Lives is now available on the AppStore and PlayStore in the UK and in Australia. The launch to wider European markets is planned for Q4 2022.

Year Invested
2022
Sector
France
close button
France
Medicus
Medicus

Medicus helps you understand your medical reports.

https://medicus.ai/

Medicus converts health data with its cryptic numbers and medical language into a visual experience with easy-to-understand health insights and actionable recommendations. The users simply have to scan their (blood) test reports, answer some questions about their current health status and finally they will receive personalized insights and recommendations. The personal data of users is a 100% private and safely stored (only) on their devices.

Year Invested
2017
Sector
Austria
close button
Austria
Bloom Diagnostics
Bloom Diagnostics

Bloom Diagnostics develops innovative technology to track, maintain, and improve your well-being.

http://bloomdiagnostics.com/

Bloom Diagnostics enables anyone to measure blood markers in a few minutes directly at home or at one of their partner locations. Relevant health information is recorded in the Bloom App and evaluated in connection with the blood sample to produce a personalized health report, containing an individual analysis and actionable information. Understandable. Fast. Fully encrypted, so that nobody can access user data without their consent.

Year Invested
2016
Sector
Austria
close button
Austria
ThinkSono
ThinkSono

ThinkSono is an advanced ultrasound diagnosis in the palm of your hand.

https://thinksono.com/

ThinkSono has created the world’s first software to diagnose ‘deep vein thrombosis’ (DVT) at the point of care. DVT is caused by a blood clot in the leg and is responsible for 800,000 deaths in Europe and the USA. ThinkSono’s solution can diagnose DVT within one step at 30 times cheaper and 10 times faster than current solutions on the market.

Year Invested
2018
Sector
United Kingdom
close button
United Kingdom
Elephant
Elephant

Elephant is a health platform based on blockchain and targeted at refugee camps and governments.

https://www.elephant.healthcare/

Elephant is a tech startup tackling big problems in global healthcare. They create lightweight, connectable applications that improve access to care and save lives. Elephant works in emerging economies and has partnered with NGOs, governments, and with healthcare professionals around the world with a view to building the future of digital health and personalized, preventative care.

Year Invested
2018
Sector
United Kingdom
close button
United Kingdom
Second Nature
Second Nature

Second Nature is inspiring and supporting to live free of any lifestyle disease.

https://www.secondnature.io/

Second Nature is a digital health program, proven to help people change their behaviors and reduce their risk to type 2 diabetes. It solves this issue by introducing a 6-week behavioral change program delivered digitally and supported by mentors and health tracking. Users receive a Second Nature smart scale and an activity tracker to track their health and outcomes. Additionally, they will be matched with a full-time coach, who will guide them through the prevention program and they learn how to prevent diabetes through Second Nature’s online education courses.

Year Invested
2017
Sector
United Kingdom
close button
United Kingdom
hi.health
hi.health

Hi.health is the contemporary approach to digitally organized personal healthcare.

https://www.hihealth.de/

hi.health offers people with private health insurance convenient and safe access to health care billing via app or web. Users can easily submit their invoices digitally and hi.health takes care of the further processing, billing and customer service providing a seamless user experience. With the integrated “library” users receive a transparent overview of relevant digital health products and services, that are (partially) covered by their insurance.

hi.health operates at the intersection of digital health, fintech and insurtech. While each of these rapidly growing markets are already exciting by themselves, their combination in one product is unique. The company was founded by Sebastian Gruber and Fredrik Debong in July 2019.

Year Invested
2019
Sector
Austria
close button
Austria
Diagnosia
Diagnosia

Diagnosia helps health professionals make better decisions by providing a search engine of drug information.

http://www.diagnosia.com/

Diagnosia (acquired by Mediately in 2022) is a mobile and web-based app, which helps doctors and other healthcare professionals make the right medication decision. Additionally, the platform serves as a highly-targeted marketing channel for pharmaceutical companies interested in advertising on the platform.

Diagnosia was founded in 2011 by a group of medical doctors, software engineers, and entrepreneurs. Over the years the company has established itself as the market leader for clinical drug information software in Austria with more than 5,000 health professionals and over 50 healthcare facilities using their app.

Year Invested
2017
Sector
Austria
close button
Austria

“Intros to players in our market helped us get to product-market fit much faster which then led to us landing €11M in Series A follow-on. Since then, we’ve grown the team to 60+ people.”

David Hahn
Founder & CEO, Remberg

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

This is some text inside of a div block.
This is some text inside of a div block.

Health Advisory Circle

Leading health and TechBio experts at your disposal.

Dr. Penny Dash
Dr. Penny Dash
Keith Gibbs
Keith Gibbs
Dr. Yacine Hadjiat
Dr. Yacine Hadjiat
Dr. Namshik Han
Dr. Namshik Han
Dr. Sven Jungmann
Dr. Sven Jungmann
Dr. Anne Phelan
Dr. Anne Phelan

From The Blog

Smart Solutions in Healthcare: How AI is Shaping the Future of Medicine

Speedinvest joins forces with Dealroom to take a detailed dive into the current landscape of trends, emerging technologies, and young companies using AI to shape the future of medicine.

TechBio Startup Overview: Analysis and Key Drivers of the Industry

Speedinvest's Daria Gherghelas and Estelle Botbol share key takeaways and the industry drivers behind TechBio in our latest report.

Femtech Investment: Analysis and Key Drivers of the Industry

VCs invested $1 billion in early-stage femtech in 2022. Speedinvest's Daria Gherghelas and Estelle Botbol untangle the data and introduce 440-plus femtech startups.

Discover more articles like these on the Speedinvest Blog

Tell us about your startup

Submit Pitch

“It was so clear and gratifying that Speedinvest had high conviction in Fertifa’s vision and team from the start. The firm's deep expertise and collective years' of experience in both health and fintech means they're the ideal fit for us and our ambitions. Additionally, their culture of "ride or die" support, hustle and no BS makes us incredibly grateful to count them as a partner.”

Eileen Burbidge MBE
Director, Fertifa

"Speedinvest is a committed partner, passionate about our cause and proactive on many fronts, from strategy, to hiring and PR. Thank you Markus, Yang, and the rest of the Speedinvest team for helping us win."

Kenneth Schlenker
Founder & CEO, Opal

"We didn't just want capital, we wanted investors who are aligned with our values and share our vision for the future of healthcare. Speedinvest have been that partner from day 1."

Martin Ratz
Co-Founder, Doccla

“From the first meeting, we knew we wanted Speedinvest as partners. Their experience in the European start-up ecosystem is unparalleled, which when combined with their support and network, makes an attractive USP. But it is the long-term relationships with the team that make Speedinvest a truly valuable partner."

Evan Floden
CEO & Founder, Seqera Labs

"Speedinvest backed us from the very beginning of our journey and have never failed to show up with their network, advice, and conviction. Six years and counting with them behind us, and I hope they are with us through the IPO."

Chris Edson
Founder & CEO, Second Nature